70% of EU Countries Lag on Tobacco Control Goals

By VirentaNews Staff — May 14, 2026

Europe’s ambition to create a tobacco-free generation by 2040 is faltering due to fragmented national policies and escalating market shifts driven by new nicotine products, according to a comprehensive study published in the Lancet Public Health. Researchers find that while public awareness of tobacco risks has improved, regulatory inconsistencies across member states allow the tobacco industry to exploit loopholes, particularly through marketing of e-cigarettes and heated tobacco products. Without robust, harmonized EU intervention, the study warns, current trajectories will fall significantly short of the European Commission’s health targets, leaving millions at continued risk of nicotine addiction and tobacco-related disease.

Rising Use of New Nicotine Products

Data from the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) Regional Office for Europe show that while traditional cigarette smoking has declined by 18% across the EU since 2010, the use of alternative nicotine delivery systems has surged. In 2023, 29% of adults in the EU reported experimenting with e-cigarettes, up from 12% in 2016, with youth usage rising even more sharply—particularly in countries like France, Germany, and Poland. A 2022 Eurobarometer survey revealed that 15% of 15–24-year-olds now use e-cigarettes regularly, many under the misconception that they are harmless. Meanwhile, sales of heated tobacco products, such as Philip Morris International’s IQOS, have grown by 217% in Central and Eastern Europe since 2020. These trends correlate with slower declines in overall nicotine dependence, undermining public health campaigns aimed at reducing long-term tobacco use.

Key Players and Their Influence

The tobacco industry remains a dominant force in shaping market dynamics, despite increased scrutiny. Major companies like Philip Morris International, British American Tobacco, and Japan Tobacco International have rebranded themselves as “smoke-free” advocates while continuing to promote alternative nicotine products through digital advertising and influencer partnerships. Internal documents obtained by the Reuters Investigates series show deliberate strategies to target younger demographics under the guise of harm reduction. At the same time, health ministries in countries such as Finland and Sweden have made progress through strict marketing bans and public education, but their efforts are often isolated. The European Commission has proposed updates to the Tobacco Products Directive, yet enforcement remains uneven, and lobbying efforts have delayed key provisions, including flavor bans and standardized packaging.

Trade-Offs in Regulation and Innovation

Policymakers face a complex balancing act: while some argue that e-cigarettes can serve as effective smoking cessation tools, public health experts caution against normalizing nicotine use, especially among youth. Studies indicate that dual use—smoking traditional cigarettes while using e-cigarettes—remains high, at around 43% among adult users, reducing the net health benefit. Additionally, the long-term health effects of inhaled flavoring agents and ultrafine particles in vapor are still under investigation. Regulatory leniency in some countries has led to a proliferation of unregulated products, while overly restrictive policies in others have driven consumers to black markets. The European Medicines Agency has approved only one nicotine-containing e-cigarette as a medicinal product, highlighting the gap between commercial availability and clinical oversight. Harmonizing regulation across the EU could mitigate these risks while preserving potential benefits for adult smokers seeking to quit.

Why the Moment Demands EU Action

The window for decisive intervention is narrowing. The European Union’s Beating Cancer Plan, launched in 2021, set a goal of reducing the number of smokers to less than 5% by 2040—a target now at risk without immediate, coordinated action. The rapid evolution of nicotine product design, coupled with aggressive cross-border marketing via online platforms, has outpaced national regulatory frameworks. Furthermore, the 2023 revision of the EU’s Tobacco Products Directive stalled in the European Parliament due to industry lobbying and member state disagreements. With the European Commission’s new mandate beginning in 2024, public health advocates are urging leadership to prioritize tobacco control as a cornerstone of EU health sovereignty, particularly in light of rising healthcare costs linked to chronic respiratory and cardiovascular diseases.

Where We Go From Here

Over the next 6–12 months, three scenarios could unfold. In the first, the European Commission adopts a strengthened, unified regulatory framework that standardizes advertising bans, flavor restrictions, and age verification across all member states, leading to a measurable decline in youth nicotine use. In the second, continued political gridlock results in a patchwork of national rules, allowing the tobacco industry to exploit regulatory arbitrage and sustain high consumption rates. In the third, public pressure and scientific consensus push key countries to form a “Tobacco-Free Alliance,” bypassing EU-wide deadlock through regional cooperation on monitoring, taxation, and public campaigns. The outcome will depend heavily on whether health agencies can counter industry narratives with clear, evidence-based communication.

Bottom line — Achieving a tobacco-free generation in Europe requires not just national commitment but decisive, harmonized action at the EU level to counter industry influence and adapt to the evolving nicotine landscape.

Source: MedicalXpress